EBS - Emergent Biosolutions Inc logo

EBS

Emergent Biosolutions Inc

Net โ€”top 1%Rev โ€”top 1%10Y
Hold

Emergent BioSolutions Inc. develops and manufactures vaccines and antibody therapeutics for public health threats, including smallpox and anthrax. It also offers emergency opioid overdose treatments and contract development services to healthcare providers.

โš•๏ธ Healthcare NYSE Listed 2006 $ USD
$1,000 invested 10 years ago โ†’$169today

Score Overview

1 Year
Scoreโ€”
Net Growthโ€”
Net Trendโ€”
Net Income Consistencyโ€”
Rev Growthโ€”
Rev Trendโ€”
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growthโ€”
Net Trend50%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendNever
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growthโ€”
Net Trend44%
Net Income Consistency
Rev Growthโ€”
Rev Trend56%
Revenue Consistency
All Time
Scoreโ€”
Net Growthโ€”
Net Trend58%
Net Income Consistency
Rev Growthโ€”
Rev Trend63%
Revenue Consistency

See the full market ranking โ†’

Emergent Biosolutions Inc fundamental performance

Across Emergent Biosolutions Inc's full reported history, from 2006 to 2025, revenue grew from $ 152M to $ 742M and net income grew from $ 22M to $ 52M. Revenue increased in 63% of the years measured; net income in 58%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 4.55โ€”
1 Year2025-08-12
$ 8.91-48.93%
5 Years2021-08-12
$ 62.69-92.74%
10 Years2016-08-12
$ 26.87-83.07%
All Time2006-11-15
$ 10.40-56.25%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 139M
2025$ 742M$ 52M$ 205M
2024$ 1.04B-$ 190M$ 99M
2023$ 1.04B-$ 760M$ 111M
2022$ 1.11B-$ 211M$ 642M
2021$ 1.77B$ 219M$ 576M
2020$ 1.57B$ 305M$ 621M
2019$ 1.10B$ 54M$ 168M
2018$ 782M$ 62M$ 112M
2017$ 560M$ 82M$ 178M
2016$ 488M$ 51M$ 271M
2015$ 489M$ 62M$ 312M
2014$ 404M$ 36M$ 280M
2013$ 312M$ 31M$ 179M
2012$ 281M$ 23M$ 141M
2011$ 273M$ 23M$ 145M
2010$ 286M$ 51M$ 171M
2009$ 234M$ 31M$ 102M
2008$ 178M$ 20M$ 91M
2007$ 182M$ 22M$ 105M
IPO2006$ 152M$ 22M$ 76M

Explore beyond EBS

You're looking at Emergent Biosolutions Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies